HBC Distribution Incorporated – Trademark Portfolio
Entity Type: 03
HBC Distribution Incorporated holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include AGE ESCAPE, AGE REPAIR, and NATURE'S CURE. The owner is based in Oakland, CA.
5560 Golden Gate Avenue
Oakland, CA 94618
Showing of trademarks Trademarks
Trademark Classifications
HBC Distribution Incorporated's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does HBC Distribution Incorporated have?
HBC Distribution Incorporated has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 abandoned, 1 cancelled.
What trademark classes does HBC Distribution Incorporated file in?
HBC Distribution Incorporated files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are HBC Distribution Incorporated's most well-known trademarks?
HBC Distribution Incorporated's registered trademark portfolio includes well-known marks such as AGE ESCAPE, AGE REPAIR, and NATURE'S CURE. These are among 4 currently registered trademarks in the portfolio.
What is HBC Distribution Incorporated's trademark registration success rate?
HBC Distribution Incorporated has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.